Evaluation of
Animals
Antibodies, Monoclonal
/ chemistry
Biological Transport
Cell Line, Tumor
Glutamate Carboxypeptidase II
/ immunology
Heterocyclic Compounds, 1-Ring
/ chemistry
Indium Radioisotopes
Isotope Labeling
Male
Mice
Radioimmunotherapy
Single Photon Emission Computed Tomography Computed Tomography
/ methods
Tissue Distribution
PSMA
SPECT
SPECT/CT
immunoimaging
monoclonal antibody
prostate cancer
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
08
05
2018
accepted:
07
09
2018
pubmed:
22
9
2018
medline:
28
10
2019
entrez:
22
9
2018
Statut:
ppublish
Résumé
5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specific membrane antigen (PSMA). PSMA is a target for the imaging and therapy of prostate cancer.
Identifiants
pubmed: 30237212
pii: jnumed.118.214403
doi: 10.2967/jnumed.118.214403
pmc: PMC6424233
doi:
Substances chimiques
Antibodies, Monoclonal
0
Heterocyclic Compounds, 1-Ring
0
Indium Radioisotopes
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Indium-111
E9NGC49E0T
Glutamate Carboxypeptidase II
EC 3.4.17.21
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
400-406Subventions
Organisme : NCI NIH HHS
ID : R01 CA157542
Pays : United States
Informations de copyright
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Discov Med. 2010 Jan;9(44):55-61
pubmed: 20102687
Semin Nucl Med. 2016 Sep;46(5):462-78
pubmed: 27553471
J Nucl Med. 2003 Apr;44(4):610-7
pubmed: 12679407
J Nucl Med. 2005 May;46(5):850-8
pubmed: 15872360
Prostate. 2018 Aug;78(11):775-789
pubmed: 29717499
Bioconjug Chem. 2016 Jun 15;27(6):1447-55
pubmed: 27076393
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541
Rev Urol. 2004;6 Suppl 10:S13-8
pubmed: 16985927
Urol Oncol. 1995 Jan-Feb;1(1):29-37
pubmed: 21224087
Mod Pathol. 2012 Aug;25(8):1079-85
pubmed: 22460809
Urology. 1998 Oct;52(4):637-40
pubmed: 9763084
EJNMMI Res. 2015 Apr 29;5:28
pubmed: 25984435
Mol Imaging Biol. 2016 Jun;18(3):437-45
pubmed: 26920354
J Nucl Med. 2005 Apr;46(4):634-41
pubmed: 15809486
Clin Cancer Res. 2016 Jan 1;22(1):9-15
pubmed: 26728408
J Nucl Med. 2015 Apr;56(4):628-34
pubmed: 25722448
Q J Nucl Med Mol Imaging. 2015 Sep;59(3):241-68
pubmed: 26213140
Prostate. 2017 May;77(7):749-764
pubmed: 28247415
Anticancer Res. 1987 Sep-Oct;7(5B):927-35
pubmed: 2449118
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998
pubmed: 29460025
Biomacromolecules. 2017 Jan 9;18(1):201-209
pubmed: 28001364
Prostate. 1997 Mar 1;30(4):232-42
pubmed: 9111600
J Nucl Med. 2009 Apr;50(4):606-11
pubmed: 19289418
Int J Cancer. 1998 May 29;76(5):738-48
pubmed: 9610734
J Nucl Med. 1993 Apr;34(4):689-94
pubmed: 8455089
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7195s-7200s
pubmed: 16203821
J Urol. 2018 Feb;199(2):370-377
pubmed: 28827104
Nat Biotechnol. 2005 Sep;23(9):1137-46
pubmed: 16151407
Cancer Res. 1997 Sep 1;57(17):3629-34
pubmed: 9288760
Clin Cancer Res. 2013 Sep 15;19(18):5182-91
pubmed: 23714732
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
J Nucl Med. 2018 May;59(5):747-748
pubmed: 29439016
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Cancer Biother Radiopharm. 2004 Dec;19(6):706-15
pubmed: 15665617
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51
pubmed: 26318602
J Nucl Med. 2017 Jan;58(1):85-90
pubmed: 27765862
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268
pubmed: 28497198
Angew Chem Int Ed Engl. 2011 Sep 19;50(39):9167-70
pubmed: 21861274
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Phys Med Biol. 2011 Feb 7;56(3):721-33
pubmed: 21220845
Clin Cancer Res. 1999 Oct;5(10):2674-81
pubmed: 10537328
Curr Drug Targets. 2009 Feb;10(2):118-25
pubmed: 19199907
J Nucl Med. 2015 Feb;56(2):293-8
pubmed: 25613537
J Clin Oncol. 2007 Feb 10;25(5):540-7
pubmed: 17290063